Listing Websites about Jazz Pharmaceuticals
Jazz Pharmaceuticals - Wikipedia
(Just Now) Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a biopharmaceutical company based in Ireland. It was founded in 2003. One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (G…
Url: Visit Now
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Bought by …
(6 days ago) 1 hour ago · Jazz Pharmaceuticals stock opened at $133.29 on Monday. Jazz Pharmaceuticals plc has a 52-week low of $117.64 and a 52-week high of $169.98. The firm has a market …
Url: Visit Now
FAQ about Jazz Pharmaceuticals
What does Jazz Pharmaceuticals plc do?
Proj. Earnings Growth Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally.
What do price records tell us About Jazz Pharmaceuticals plc (jazz)?
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Jazz Pharmaceuticals plc shares are logging -22. 10% during the 52-week period from high price, and 12. 56% higher than the lowest price point for the same timeframe.
What was the moving average for Jazz Pharmaceuticals plc (jazz) in 100 days?
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 150.95, with a change in the price was noted -20.22. In a similar fashion, Jazz Pharmaceuticals plc posted a movement of -13.25% for the period of last 100 days, recording 531,259 in trading volumes.
What are analysts' target prices for Jazz Pharmaceuticals' stock?
15 Wall Street analysts have issued 1-year target prices for Jazz Pharmaceuticals' stock. Their predictions range from $135.00 to $208.00. On average, they expect Jazz Pharmaceuticals' share price to reach $169.29 in the next year.